Skip to main content
. 2021 Mar 1;92(8):897–907. doi: 10.1136/jnnp-2020-325302

Figure 1.

Figure 1

Interpretation of the neuronal autoantibody panel. *Anti-Hu (ANNA-1), anti-Ri (ANNA-2), ANNA-3, anti-SOX1 (AGNA), anti-amphiphysin, anti-CRMP-5 (anti-CV2), anti-Yo (PCA-1), PCA-2, high-titre anti-GAD65. **Anti-NMDA-R, anti-LGI1, anti-CASPR2, anti-AMPA-R, anti-GABA-A/B, PCA-Tr, anti-DPPX, anti-mGluR1, anti-mGluR2, anti-mGluR5, anti-IgLON5, anti-AQP4, anti-MOG. ***Non-LGI1 non-CASPR2 anti-VGKC, anti-P/Q VGCC, anti-N VGCC, Ach-b, Ach-M, Ach-G, Striational. Low-titre anti-GAD65 is an antibody against cytoplasmic antigen but is of questionable clinical significance. Adapted with permission from George et al.40